Related Experiment Videos
Tumor cell dyscohesion in carcinoma of the breast
American Journal of Clinical Pathology
|November 5, 1998
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Including tumor-infiltrating lymphocytes into the PREDICT prognostic model for triple-negative breast cancer survival.
Annals of oncology : official journal of the European Society for Medical Oncology·2026
Tumor infiltrating lymphocytes and change in tumor load on MRI to assess response and prognosis after neoadjuvant chemotherapy in breast cancer.
Breast cancer research and treatment·2024
Tumor-infiltrating lymphocytes and immune-related adverse events in advanced melanoma.
Immuno-oncology technology·2024
Biomedical students' satisfaction with and engagement in laboratory e-learning support are related to their self-regulation.
Biochemistry and molecular biology education : a bimonthly publication of the International Union of Biochemistry and Molecular Biology·2024
Saline whole-blood impedance aggregometry for detection of heparin-independent platelet-activating anti-platelet factor 4 antibodies.
American journal of clinical pathology·2026
BRAF V600E-mutated marginal zone lymphoma may exhibit features that partially overlap with hairy cell leukemia.
American journal of clinical pathology·2026
Clinical and molecular spectrum of VEXAS with multiple UBA1 variants: case study and literature review.
American journal of clinical pathology·2026
Preanalytical variables in surgical pathology: practical sources of diagnostic error before microscopic interpretation.
American journal of clinical pathology·2026
How I diagnose Erdheim-Chester disease.
American journal of clinical pathology·2026
Risk factors for lymph node metastasis in a contemporary radical prostatectomy cohort.
American journal of clinical pathology·2026
Lymphatic vascular aging and age-related bone loss: current status and future perspectives.
Frontiers in immunology·2026
Microbiota-driven metabolic-immune crosstalk in breast cancer.
Frontiers in pharmacology·2026